Ignite Creation Date:
2025-12-24 @ 5:13 PM
Ignite Modification Date:
2026-01-01 @ 6:52 AM
Study NCT ID:
NCT06654050
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-24
First Post:
2024-10-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma
Sponsor:
Organization: